NOVONIX Limited filings document foreign-issuer reports furnished on Form 6-K, with exhibits drawn from ASX announcements and corporate notices. The record includes disclosures on annual general meeting presentations and voting results, material-event updates, material agreements, operating and financial results, and governance matters tied to the company's battery materials business.
Capital-structure filings cover applications for quotation of ordinary fully paid securities, securities issued from option exercises or convertible-security conversions, performance rights, and director interest notices. These filings also record shareholder voting matters and formal updates relevant to NOVONIX's ADR and foreign-issuer reporting framework.
Novonix Limited has reported a change in its board of directors. The company submitted a report to U.S. regulators highlighting an attached announcement from the Australian Securities Exchange.
The exhibit notes the appointment of Mike O'Kronley to the Board of Directors, dated December 15, 2025. This update formally records the new board role for investors who follow Novonix through U.S. markets.
Novonix Limited furnished a Form 6‑K for November 2025 to provide investors with an ASX announcement titled “Notice of Termination of Offtake Agreement” dated November 4, 2025. The report is signed on behalf of the company by Chief Financial Officer Robert Long.